ZTS stock forecast
Our latest prediction for Zoetis, Inc.'s stock price was made on the Aug. 20, 2018 when the stock price was at 92.16$.
In the short term (2weeks), ZTS's stock price should outperform the market by 0.21%. During that period the price should oscillate between -3.19% and +2.97%.
In the medium term (3months), ZTS's stock price should outperform the market by 0.31%. During that period the price should oscillate between -8.16% and +9.33%.Get email alerts
About Zoetis, Inc.
Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.
At the moment the company generates 6260M USD in revenues.
On its last earning announcement, the company reported a profit of 3.11$ per share.
The book value per share is 4.09$
Three months stock forecastAug. 20, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|